- Open Access
Next-generation sequencing reveals large connected networks of intra-host HCV variants
© Campo et al.; licensee BioMed Central Ltd. 2014
- Published: 14 July 2014
Next-generation sequencing (NGS) allows for sampling numerous viral variants from infected patients. This provides a novel opportunity to represent and study the mutational landscape of Hepatitis C Virus (HCV) within a single host.
Intra-host variants of the HCV E1/E2 region were extensively sampled from 58 chronically infected patients. After NGS error correction, the average number of reads and variants obtained from each sample were 3202 and 464, respectively. The distance between each pair of variants was calculated and networks were created for each patient, where each node is a variant and two nodes are connected by a link if the nucleotide distance between them is 1. The work focused on large components having > 5% of all reads, which in average account for 93.7% of all reads found in a patient.
The distance between any two variants calculated over the component correlated strongly with nucleotide distances (r = 0.9499; p = 0.0001), a better correlation than the one obtained with Neighbour-Joining trees (r = 0.7624; p = 0.0001). In each patient, components were well separated, with the average distance between (6.53%) being 10 times greater than within each component (0.68%). The ratio of nonsynonymous to synonymous changes was calculated and some patients (6.9%) showed a mixture of networks under strong negative and positive selection. All components were robust to in silico stochastic sampling; even after randomly removing 85% of all reads, the largest connected component in the new subsample still involved 82.4% of remaining nodes. In vitro sampling showed that 93.02% of components present in the original sample were also found in experimental replicas, with 81.6% of reads found in both. When syringe-sharing transmission events were simulated, 91.2% of all simulated transmission events seeded all components present in the source.
Most intra-host variants are organized into distinct single-mutation components that are: well separated from each other, represent genetic distances between viral variants, robust to sampling, reproducible and likely seeded during transmission events. Facilitated by NGS, large components offer a novel evolutionary framework for genetic analysis of intra-host viral populations and understanding transmission, immune escape and drug resistance.
- Next Generation Sequencing
- Transmission Event
- Large Connected Component
- Nucleotide Distance
- Patristic Distance
Hepatitis C virus (HCV) infects nearly 3% of the world's population and is a major cause of liver disease worldwide . There is no vaccine against HCV and up to recently standard-of-care therapy involved the combined use of pegylated interferon (peg-IFN) and ribavirin (RBV). This combination therapy is expensive, effective in only 50%-60% of patients, and can be associated with frequent and serious adverse side effects in >75% of patients [2, 3].
HCV is genetically very heterogeneous and classified into 7 genotypes and numerous subgenotypes . HCV changes continuously during chronic infection, showing a complex dynamics of intra-host viral subpopulations . The most studied HCV region is the hypervariable region 1 (HVR1) located at amino acid (aa) positions 384-410 in the structural protein E2. Sequence variation in HVR1 correlates with neutralization escape and is associated with viral persistence during chronic infection [6–11].
Recent advances in next-generation sequencing (NGS) methods allow for analysis of the unprecedented number of HVR1 sequence variants from infected patients and present a novel opportunity for understanding intra-host HCV evolution, drug resistance and immune escape . HCV HVR1 variants sampled using NGS from infected individuals were studied here. We report, for the first time, that most variants are organized into large single-mutation connected components. This finding presents a novel framework for genetic analysis of intra-host HCV populations, relevant to the study of viral transmission, immune escape and drug resistance.
Network topological analysis
All components showed a skewed degree distribution. Although not strictly following a power-law degree distribution, most nodes are incident only to one or two links. The shortest path distances among all pairs of sequences were estimated, and then the average shortest path distance for each component was calculated. Over all components, the average pairwise distance shortest path was 4.06 (S.E.M. = 0.14), whereas the diameter was 9.24 (S.E.M. = 0.41). Interestingly, the nodes in the component did cluster very little (as measured by clustering coefficient, average over all patients = 0.0071, S.E.M. = 0.002). A low clustering coefficient indicates the absence of triangles in the network. The only way to form a triangle is to have three sequences that are one mutation away from each other at the same nucleotide position. The absence of this network motif simply indicates that close sequences of this HCV genomic region often differ at distant positions, instead of differing in states of the same position.
In silicosampling robustness
Simulated transmission events
We simulated unsafe injection-related transmission events using estimates of the number of virions (n = 24) that may establish productive infection of liver from contaminated syringes (Methods section). In order to simulate the transmission event, a random subsample (recipient) of only 24 reads was taken from the reads of a given patient (source). For each recipient sample, we tested the number of components from the source represented by the sampled reads. Importantly, we found that 91.20% of all simulated transmission events seeded all components present in the source (S.E.M. = 0.57%), indicating that viral variants that have established infection in a recipient after transmission likely represent all components existing in the source, thus allowing for the potential reconstitution of these components from a small but heterogeneous founder population.
Differences among components
RNA viruses exhibit extremely high mutation rates and given the large population sizes observed in both experimental and natural infections with these viruses, every possible point mutation and many double-mutation combinations could theoretically be generated during each replication cycle within a population. The mutability of each viral genome means that RNA virus populations exist as dynamic mutant networks in which sequences are continuously diversified and regenerated by mutation of related sequences, often known as a quasispecies . Connecting viral variants that differ in one mutation provides a natural framework to organize the heterogeneous population of viral variants. Although this has been achieved on theoretical landscapes (e.g. RNA secondary structures), here we have built these one-step networks for the first time using viral experimental data, a development just recently enabled by the NGS technology.
Analyses conducted using in silico and experimental sampling showed significant robustness of the component to stochastic variation, implying that a true component will not be split into two due to poor sampling. Another advantage of the network framework is that several topological parameters can be calculated (e.g., degree distribution, eigenvector centralities, modularity, motif distribution) for a given patient and then used to test for differences among different phenotype groupings (e.g., acute vs. chronic patients, or responders vs. non-responders of antiviral therapy). Although this topological comparison was not performed in the present research, this network framework provides a new potential tool for comparing viral populations.
The simulated transmission events may seem too simplified, as selective pressure in the new host environment will likely be different, affecting intra-host evolution in a different way. However, the simulation does not deal with the survival of those seeds, only with their likelihood of being transmitted. This is in agreement with many reports on HCV outbreaks, where it is very common that newly infected cases share variants and are genetically very close to the transmission source . Based on this, the purpose of the simulation was to show a very simple phenomenon: if transmission is purely stochastic (there are not differences in transmissibility among variants), then the variants present in the source will be transmitted to the incident case in proportion to their frequency. As was shown in the transmission simulation experiments, the high frequency of components allows a small random sample of 20-30 variants to represent with high probability all of these components in each intra-host viral population. This important property facilitates reconstitution of the same component composition of intra-host viral population from the small number of founder variants transmitted from one host to another.
The level of genetic separation among large components indicates that exploration of all the components in each infected host likely cannot be accomplished via a single mutation starting from a single viral variant. The existence of several subpopulations organized in one-step components in each infected individual studied here suggests that the founder viral population was complex, in agreement with recent findings . The data obtained in this study indicate that the mechanism of stochastic sampling is compatible with the complex founder model and further experiments are underway to resolve this issue.
HCV changes continuously during chronic infection, showing a complex dynamics of intra-host viral subpopulations . Large components of HCV variants obtained from follow-up samples could be used to define viral subpopulations, whose shifts in frequency over time can be tracked to pinpoint the sources of drug resistance or immune escape. The one-step connection provides a simple biological criterion for identifying the genetic structure of viral subpopulations. When sampling of intra-host viral variants is done using NGS, the one-step components can be generated for clustering closely related variants without any assumption on their ancestral origin. The genetic space occupied by the variants of a given component will likely be explored very rapidly via single mutations starting from any variant in each component. The estimation of the amount of time needed for this exploration should take into account the kinetic parameters of HCV infection (population size, mutation rate, doubling time, liver volume, etc.). These are currently being investigated in our laboratory. Given that some patients harbour a mixture of positively and negatively selected components, the subpopulations defined by components may experience different selection pressures, accounting for the frequency shifts observed during intra-host evolution in some patients .
The distances calculated over the component were found to be almost identical to the Hamming distances calculated for all variants, which allows for better visualizing local and global relationships among sequences and among clusters. It must be noted that other popular representations of the distance matrix, such as hierarchical bifurcating trees or Multi-Dimensional Scaling, reduce dimensionality of data at the cost of accuracy of distance representation among genetic variants. We have shown here that patristic distances calculated over the Neighbor-Joining tree have a significantly lower correlation with the distance matrix than the one-step components. A good phylogenetic tree presents a single most likely history of substitutions, all of which collectively generated the dataset. However, the key point of our work is that a single history is an over-simplification when the whole quasispecies network is continuously generated over multiple parallel paths. This network setting fits better the highly dynamic process which is the result of HCV's large population size, high mutation rate and fast doubling time.
Although NGS has been instrumental in the acquisition of a massive number of genomic sequences, the contribution of these sequences to understanding intra-host viral evolution have been modest, considering the enormous amount of genetic information generated by the technology . This paradox can, in part, be explained by the shortage of computational methods for verifying the accuracy of generated sequences and accommodating large datasets. However, extensive sequencing of intra-host viral variants offers also novel opportunities for analysing genetic information, which are not available for small samples of sequences. One such approach was developed in this study. We have shown that one-step components represent accurately genetic relationships among the HCV HVR1 variants extensively sampled by NGS from infected individuals. This likely reflects sampling of numerous intermediates and/or co-existent ancestors, which allows the parsimonious reconstruction of the evolutionary process responsible for generation of the intra-host viral population.
The majority of intra-host HVR1 variants form large connected components in infected patients. These large components preserve true distances among variants, are well separated from each other, are robust to sampling, and are likely seeded during transmission events. Large components identified through NGS-facilitated deep sampling offer a novel evolutionary framework for genetic analysis of intra-host HCV populations to characterise viral factors relevant to transmission, immune escape and drug-resistance.
Intra-host HCV variants were extensively sampled from 58 chronically infected patients with genotypes 1 or 3. Ethical review and informed consent were granted by the institutional review boards of Beth Israel Deaconess Medical Center and the Centers for Disease Control and Prevention.
Nucleic acid extraction
Total nucleic acids from the specimens were extracted from serum using the Roche MagNA Pure LC instrument and the MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche Diagnostics, Mannheim, Germany). RNA was precipitated and reverse-transcribed using both random and specific primers as previously described . PCR quantification was conducted by the COBAS AmpliPrep/COBAS Taq-Man HCV Test (Roche Diagnostics, Mannheim, Germany), and HCV genotype determined using the VERSANT HCV Genotype 2.0 Assay (LiPA) (Innogenetics NV, Gent, Belgium).
HVR1 cDNA amplification
The E1/E2 junction of the HCV genome (309 nt), which contains the HVR1 region, was amplified using our nested PCR protocol as previously described . The amplicons generated during first-round PCR were used as templates for nested PCR using hybrid primers composed of primer adaptors, multiple identifiers and specific sequences complementary to the HCV genome. This strategy allowed for multiplexing and downstream pyrosequencing. Resulting amplicons were quantified using the Picogreen kit (Invitrogen, Carlsbad, CA). Integrity of each fragment was evaluated using Bioanalyzer 2100 (Agilent, Santa Clara, CA).
Next Generation Sequencing (NGS)
PCR products were pooled and subjected to pyrosequencing using the GS FLX System and the GS FLX Titanium Sequencing Kit (454 Life Sciences, Roche, Branford, CT). Low-quality reads were removed using the GS Run Processor v2.3 (Roche). Initial reads were processed by matching to the corresponding identifier. The 454 files were processed using the error correction algorithms KEC and ET , which have been validated to be highly accurate in finding true haplotypes, estimate their frequencies and remove false ones. The error-corrected files were aligned using Muscle  and the HVR1 sequences clipped to 303 bp.
The E1/E2 sequences produced in this study can be found in the following link: http://alan.cs.gsu.edu/~skumsp/BMC_genomics.fas. The name of the sequence includes the patient name, a unique identifier, the genotype and the absolute frequency (number of reads).
The distance between each pair of variants was calculated and networks were created for each patient, where each node is a variant and two nodes are connected by a link if the nucleotide distance between them is 1. The present work was focused on large components having more than 5% of all reads. Most analyses in this paper were performed with MATLAB R2011b (The MathWorks, Inc., Natick, MA). Network visualization was achieved with the programs Pajek  and Gephi .
In order to visualize how distant or similar the one-step components are, a simple method for parsimoniously connect the components was devised. The k-step network method consist of the following steps: (i) calculation of the Hamming distance between each pair of variants belonging to different one-step components; (ii) determination of the minimum among these distances; and (iii) establishment of a link among the variants belonging to different one-step components that have this minimal distance.
For each component, bootstrap samples with replacement were created. Briefly, a number of reads equal to a defined percentage of the original number of reads was taken randomly from the original component. The procedure was repeated at different sampling levels, with decreasing number of reads in 10% intervals. For each component and sampling level, the procedure was repeated 1000 times. For each sample, the one-step network was built and the size of the largest component was calculated. An average over all samples and a 99% confidence interval were calculated.
Simulation of transmission events
The average needle-sharing event would transmit 24 virions, a number based on the following estimates: 2 uL of blood contaminates a syringE ; 1 × 107 virions per 1000uL of blood ; the infection rate is 1.5 × 10-6 per mL/virion/day ; and an average liver volume of 1400 mL . In order to simulate the transmission event, we took all the reads of patient (source) and created a subsample with replacement made of 24 reads (recipient), a process that was repeated 1000 times per patient. For each recipient sample, we tested how many components present in the source were represented by one or more reads.
Evidence of selection
For each component, we calculated the overall ratio of nonsynonymous substitutions on nonsynonymous sites (dN) over the synonymous substitutions on synonymous sites (dS) with a modified version of the single-likelihood ancestor counting (SLAC) algorithm . In our approach, rather than counting the number of substitutions for each codon over the branches of the phylogenetic tree, the number of substitutions was counted over all the edges of the one-step component.
Publication costs for this article were funded by the corresponding author's institution, the Centers for Disease Control and Prevention.
This article has been published as part of BMC Genomics Volume 15 Supplement 5, 2014: Selected articles from the Third IEEE International Conference on Computational Advances in Bio and Medical Sciences (ICCABS 2013): Genomics. The full contents of the supplement are available online at http://www.biomedcentral.com/bmcgenomics/supplements/15/S5.
- Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST: Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2012Google Scholar
- Hsu CS, Liu CJ, Lai MY, Chen PJ, Kao JH, Chen DS: Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan. Intervirology. 2007, 50 (4): 310-315. 10.1159/000105444.PubMedView ArticleGoogle Scholar
- Aghemo A, Rumi MG, Colombo M: Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C. Expert review of anti-infective therapy. 2009, 7 (8): 925-935. 10.1586/eri.09.70.PubMedView ArticleGoogle Scholar
- Simmonds P: Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol. 2004, 85: 3173-3188. 10.1099/vir.0.80401-0.PubMedView ArticleGoogle Scholar
- Ramachandran S, Campo D, Dimitrova Z, Xia G, Purdy M, Khudyakov Y: Temporal Variations in the Hepatitis C Virus Intra-Host Population During Chronic Infection. J virol. 2011, 85 (13): 6369-6380. 10.1128/JVI.02204-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Van Doorn L, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, Schellekens H, Quint W: Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol. 1995, 69 (2): 773-778.PubMedPubMed CentralGoogle Scholar
- Eckels D, Zhou H, Bian T, Wang H: Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus. Int Immunol. 1999, 11 (4): 577-583. 10.1093/intimm/11.4.577.PubMedView ArticleGoogle Scholar
- Wang H, Bian T, Merrill S, Eckels D: Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection. J Mol Evol. 2002, 54 (4): 465-473. 10.1007/s00239-001-0037-6.PubMedView ArticleGoogle Scholar
- Pavio N, Lai M: The Hepatitis C Virus Persistence: How To Evade The Immune System?. J Biosci. 2003, 3: 287-304.View ArticleGoogle Scholar
- Isaguliants M: Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy. Curr Pharm Biotechnol. 2003, 4 (3): 169-183. 10.2174/1389201033489856.Google Scholar
- Lopez-Labrador F, Berenguer M, Sempere A, Prieto M, Sirera R, Gonzalez-Molina A, Ortiz V, Marty M, Berenguer J, Gobernado M: Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C. Liver Transpl. 2004, 10 (2): 217-227. 10.1002/lt.20066.PubMedView ArticleGoogle Scholar
- Wang G, Sherrill-Mix S, Chang K, Quince C, Bushman F: Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J Virol. 2010, 84 (12): 6218-6228. 10.1128/JVI.02271-09.PubMedPubMed CentralView ArticleGoogle Scholar
- Lauring AS, Frydman J, Andino R: The role of mutational robustness in RNA virus evolution. Nature reviews Microbiology. 2013, 11 (5): 327-336. 10.1038/nrmicro3003.PubMedPubMed CentralView ArticleGoogle Scholar
- Ganova-Raeva L, Dimitrova Z, Campo D, Lin Y, Ramachandran S, Xia G, Honisch C, Cantor C, Khudyakov Y: Detection of hepatitis C virus transmission using mass spectrometry. Journal of Infectious Diseases. 2013, 207 (6): 999-1006. 10.1093/infdis/jis938.PubMedView ArticleGoogle Scholar
- Li H, Stoddard MB, Wang S, Blair LM, Giorgi EE, Parrish EH, Learn GH, Hraber P, Goepfert PA, Saag MS, et al: Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing. PLoS Pathog. 2012, 8 (8): e1002880-10.1371/journal.ppat.1002880.PubMedPubMed CentralView ArticleGoogle Scholar
- Ramachandran S, Xia GL, Ganova-Raeva LM, Nainan OV, Khudyakov Y: End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods. 2008, 151 (№2): 217-224.PubMedView ArticleGoogle Scholar
- Skums P, Dimitrova Z, Campo DS, Vaughan G, Rossi L, Forbi JC, Yokosawa J, Zelikovsky A, Khudyakov Y: Efficient error correction for next-generation sequencing of viral amplicons. BMC Bioinformatics. 2012, 13 (Suppl 10): S6-10.1186/1471-2105-13-S10-S6.PubMedPubMed CentralView ArticleGoogle Scholar
- Edgar R: MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004, 32 (5): 1792-1797. 10.1093/nar/gkh340.PubMedPubMed CentralView ArticleGoogle Scholar
- Batagelj V, Mrvar A: Pajek - Analysis and Visualization of Large Networks. Graph Drawing Software. Edited by: Juenger M, Mutzel P. Berlin: Springer. 2003, 77-103.Google Scholar
- Bastian MSH, Jacomy M: Gephi:an open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and Social Media. 2009, San Jose,CA, 361-362.Google Scholar
- Zule WA, Cross HE, Stover J, Pretorius C: Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. The International journal on drug policy. 2013, 24 (1): 1-7. 10.1016/j.drugpo.2012.07.002.PubMedView ArticleGoogle Scholar
- Neumann A, Lam N, Dahari H, Gretch D, Wiley T, Layden T, Perelson A: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998, 282: 103-107.PubMedView ArticleGoogle Scholar
- Powers KA, Ribeiro RM, Patel K, Pianko S, Nyberg L, Pockros P, Conrad AJ, McHutchison J, Perelson AS: Kinetics of hepatitis C virus reinfection after liver transplantation. Liver Transpl. 2006, 12 (2): 207-216. 10.1002/lt.20572.PubMedView ArticleGoogle Scholar
- Chang M, Williams O, Mittler J, Quintanilla A, Carithers RL, Perkins J, Corey L, Gretch DR: Dynamics of hepatitis C virus replication in human liver. The American journal of pathology. 2003, 163 (2): 433-444. 10.1016/S0002-9440(10)63673-5.PubMedPubMed CentralView ArticleGoogle Scholar
- Kosakovsky S, Frost S: Not so different after all: A comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005, 22 (5): 1208-1222. 10.1093/molbev/msi105.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.